(19)
(11) EP 1 349 577 A2

(12)

(88) Date of publication A3:
31.07.2003

(43) Date of publication:
08.10.2003 Bulletin 2003/41

(21) Application number: 01989317.1

(22) Date of filing: 02.11.2001
(51) International Patent Classification (IPC)7: A61K 47/48
(86) International application number:
PCT/US0151/151
(87) International publication number:
WO 0204/7730 (20.06.2002 Gazette 2002/25)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 06.11.2000 US 707730

(71) Applicant: Asilomar Pharmaceuticals, Inc.
Woodside, CA 94062-2446 (US)

(72) Inventors:
  • HILL, Gordon, Craig
    Stockton, CA 95209 (US)
  • KAHL, Stephen, B.
    Portola Valley, CA 94028 (US)
  • WEBB, Robert
    Moss Beach, CA 94038 (US)
  • MCKEE, Constance, A.
    Woodside, CA 94062-2446 (US)

(74) Representative: Brasnett, Adrian Hugh et al
Mewburn EllisYork House23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)

   


(54) INTRACELLULAR DELIVERY OF CHARGED THERAPEUTIC MOIETIES TO NERVE CELLS BY MEANS OF TARGETING PROTEINS